U.S. flag An official website of the United States government.
Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

i

Species and Sex-Dependent Toxicokinetics of 1-Bromopropane: The Role of Hepatic Cytochrome P450 Oxidation and Glutathione (GSH)



Details

  • Personal Author:
  • Description:
    1. The objectives of the current studies were to evaluate the factors influencing the toxicokinetics of 1-bromopropane (1-BP) in rodents after intravenous (IV) and inhalation exposure. 2. F-344 rats were administered 1-BP via IV bolus injection at 5 and 20 mg/kg and blood concentration determined versus time. F-344 rats and B6C3F1 mice were also exposed to starting inhalation concentrations 70, 240, 800 and 2700 ppm 1-BP in a closed gas uptake system and chamber 1-BP levels were monitored for 6 h. Plasma bromide concentrations were determined to estimate total metabolized dose. Rats were pretreated with chemical inhibitors of cytochrome P450 and glutathione (GSH) synthesis, prior to exposure to 1-BP at 800 ppm within inhalation chambers. 3. Systemic clearance of 1-BP in rat was rapid and decreased with increasing dose. As inhalation chamber concentration of 1-BP increased, the terminal elimination rates decreased. Half-life of 1-BP in rats following inhibition of P450 (9.6 h) or depletion of GSH (4.1 h) increased relative to controls (2.0 h) at 800 ppm. The percentage of 1-BP metabolized decreased with increasing inhalation exposure. Hepatic levels of GSH were significantly lowered regardless of the exposure level in both rats and mice. Chamber concentration-time curves were fit to a two compartment model which was used to estimate metabolic rate constants. 4. These data suggest that in rat, 1-BP clearance is saturable and that elimination is highly dependent on both P450 and GSH-dependent metabolism. This investigation in rodents may provide an understanding of interspecies differences in toxicokinetics and eventually aid translation of animal studies to human risk assessment. [Description provided by NIOSH]
  • Subjects:
  • Keywords:
  • ISSN:
    0049-8254
  • Document Type:
  • Funding:
  • Genre:
  • Place as Subject:
  • CIO:
  • Topic:
  • Location:
  • Volume:
    44
  • Issue:
    7
  • NIOSHTIC Number:
    nn:20053962
  • Citation:
    Xenobiotica 2014 Jul; 44(7):644-656
  • Contact Point Address:
    C. Edwin Garner, Metabolism and Pharmacokinetics, Lovelace Respiratory Research Institute, Albuquerque, New Mexico, USA
  • Email:
    Halifax_garner@yahoo.com
  • CAS Registry Number:
  • Federal Fiscal Year:
    2014
  • Performing Organization:
    University of Georgia, Athens
  • Peer Reviewed:
    True
  • Start Date:
    20130901
  • Source Full Name:
    Xenobiotica
  • End Date:
    20160831
  • Collection(s):
  • Main Document Checksum:
    urn:sha-512:51b4c70c58d066bd117af3a9d015a44ea5fbc2845d2b7eccefe2076edf9d0a1e595fd333cd63cfff7446bbe0cbc3800a48cc018640c41b1f24e98461e604b0f1
  • Download URL:
  • File Type:
    Filetype[PDF - 1.97 MB ]
ON THIS PAGE

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.